Abstract
\nFew options are available for treating patients with advanced prostate cancer (PC). As PC is a slow growing disease and accessible by ultrasound, gene therapy could provide a viable option for this neoplasm. Conditionally replication?competent adenoviruses (CRCAs) represent potentially useful reagents for treating prostate cancer (PC). We previously constructed a CRCA, Cancer Terminator Virus (CTV), which showed efficacy both in vitro and in vivo for PC. The CTV was generated on a serotype 5?background (Ad.5?CTV) with infectivity depending on Coxsackie?Adenovirus Receptors (CARs). CARs are frequently reduced in many tumor types, including PCs thereby limiting effective Ad?mediated therapy. Using serotype chimerism, a novel CTV (Ad.5\/3?CTV) was created by replacing the ...<\/p>\n
MedWorm Sponsor Message:<\/i><\/b> Find the best Christmas presents and January Sales<\/a> in the UK with this simple shopping directory.<\/p>\n<\/div>\n Source: Abstract Few options are available for treating patients with advanced prostate cancer (PC). As PC is a slow growing disease and accessible by ultrasound, gene therapy could provide a viable option for this neoplasm. Conditionally replication?competent adenoviruses (CRCAs) represent potentially … Continue reading
http:\/\/www.medworm.com\/index.php?rid=7435952&cid=c_449_171_f&fid=33777&url=http%3A%2F%2Fonlinelibrary.wiley.com%2Fresolve%2Fdoi%3FDOI%3D10.1002%252Fjcp.24408<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"